Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield Texas GGT Update | OpenPaye…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - TexasPolicy RPLAB056

    Gamma-glutamyl Transferase in Adults

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Texas Policy RPLAB056 alerts

    Get alerted when Policy RPLAB056 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This reimbursement policy governs when serum gamma-glutamyl transferase (GGT) testing may be reimbursable for individuals age 18 or older. It allows limited-frequency testing for specified clinical indications and excludes testing during asymptomatic wellness or general examinations without abnormal findings.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyGamma-glutamyl Transferase in Adults
    Policy CodePolicy RPLAB056
    Change TypeMaterial update
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionSubmit serum GGT testing for reimbursement only when the patient is age 18 or older, a listed clinical indication is documented, and testing occurs no more than once every two weeks.
    SourceLink
    POLICY UPDATE CHANGES

    The policy added that primary or secondary malignant neoplasms must involve the digestive system to support the specified GGT testing criterion.

    The criterion for assessing liver function after liver transplantation was revised for clarity.

    The policy added a clarification that the reimbursement criteria apply only to individuals age 18 years or older.

    18+Minimum age to which the criteria apply
    Every 2 weeksMaximum reimbursable testing frequency for qualifying indications
    15

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Qualifying clinical conditions or indications listed for liver injury, function, or disease assessment
    Not reimbursableAsymptomatic GGT testing during a wellness visit or general examination without abnormal findings
    82977Listed CPT assay code for GGT

    Reimbursable GGT Testing

    Reimbursable Adult Testing with Qualifying Indication

    Serum GGT testing may be reimbursable when ALL of the following criteria are met:

    ALL of the following

    • Individual is 18 years of age or older.
    • Serum GGT testing is performed no more than once every two weeks.
    • At least ONE qualifying clinical indication

      • Elevated alkaline phosphatase activity.
      • Assessment of liver injury, function, and/or disease in the presence of at least one qualifying condition: chronic alcohol use; long-term drug therapy with potential for liver toxicity; exposure to hepatotoxins; viral hepatitis, amoebiasis, tuberculosis, psittacosis, or similar infections that may cause hepatic injury; primary or secondary malignant neoplasms of the digestive system; diabetes mellitus; malnutrition; disorders of iron and mineral metabolism; sarcoidosis; amyloidosis; lupus; hypertension; gastrointestinal disease; pancreatic disease; or need to assess liver function subsequent to liver transplantation.

    Excluded Asymptomatic Wellness or General Examination Testing

    Serum GGT testing is not reimbursable when ALL of the following apply:

    ALL of the following

    • Individual is asymptomatic.
    • Testing is performed during a wellness visit or general examination.
    • There are no abnormal findings.

    Code and Frequency Parameters

    Gamma-glutamyl transferase assayCPTCovered
    82977ASSAY OF GGT
    Patient Age
    Minimum patient age18 years
    Policy populationIndividuals 18 years of age or older
    Younger individualsCriteria do not apply to individuals less than 18 years of age
    Testing Frequency
    Maximum frequencyNo more than once every two weeks
    Applies toSerum GGT testing for qualifying clinical indications
    Qualifying use exampleTesting for individuals with elevated alkaline phosphatase activity may be reimbursable at this frequency

    Submission and Documentation Requirements

    Billing Rule

    Apply adult clinical criteria and frequency limit

    Submit serum GGT testing for reimbursement only when the patient is age 18 or older and a listed clinical indication is documented. Qualifying testing may be performed no more than once every two weeks.

    • Confirm the patient is at least 18 years of age.
    • Document a qualifying indication, such as elevated alkaline phosphatase activity or a condition requiring assessment of liver injury, function, or disease.
    • Do not exceed a testing frequency of once every two weeks.
    Documentation Required

    Maintain accurate claim documentation

    Submit accurate documentation of services performed and use valid code combinations consistent with applicable coding guidelines. Provide additional documentation when requested.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyGamma-glutamyl Transferase in Adults
    Policy CodePolicy RPLAB056
    Change TypeMaterial update
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionSubmit serum GGT testing for reimbursement only when the patient is age 18 or older, a listed clinical indication is documented, and testing occurs no more than once every two weeks.
    SourceLink
    On This Page
    Reimbursable GGT TestingCode and Frequency ParametersSubmission and Documentation Requirements
    • Code services using applicable HIPAA-approved code sets.
    • Follow industry-standard coding guidelines and applicable code-edit protocols.
    Denial Risk

    Avoid nonreimbursable screening use

    Do not submit asymptomatic GGT testing performed during a wellness visit or general examination without abnormal findings as reimbursable.

    • Do not bill serum GGT testing for an asymptomatic individual in these settings when there are no abnormal findings.